Depolymerization of HMW into a predicted LMW chitosan and determination of the degree of deacetylation to guarantee its quality for research use

Amjad M. Qandil*a,b, Tamara J. Marjic, Bashar M. Al-Taanid, Aseel H. Khalede, Adnan A. Badwan*e "Depolymerization of HMW into a predicted LMW chitosan and determination of the degree of deacetylation to guarantee its quality for research use”.  International Pharmaceutical Excipients Council, IPEC Americas, Received: April 11, 2018; Accepted: April 15, 2018

 

Please click here to see the article.

Insights From Practice With Use of Direct Oral Anticoagulants in Transplantation

Razan Alsheikh, PharmD, BCPS1,2Osamah M. Alfayez, PharmD, CDE2,3, and Majed S. Al Yami, PharmD, BCPS, ASH-CHC4 "Insights From Practice With Use of Direct Oral Anticoagulants in Transplantation”.  Progress in Transplantation 1-6 ª 2018, NATCO

 

Please click here to see the article.

Direct oral anticoagulants for extended thromboprophylaxis in medically ill patients: meta-analysis and risk/benefit assessment

Majed S Al Yami1,2 Sawsan Kurdi2,3 Ivo Abraham2,4,5  "Direct oral anticoagulants for extended thromboprophylaxis in medically ill patients: meta-analysis and risk/benefit assessment”.  Journal of Blood Medicine 2018:9 25–34

 

Please click here to see the article.

Prevalence, patterns and predictors of depression treatment among community dwelling older adults with stroke in the United States: a cross sectional study

Sandipan Bhattacharjee1*, Majed Al Yami2, Sawsan Kurdi2 and David Rhys Axon1  "Prevalence, patterns and predictors of depression treatment among community dwelling older adults with stroke in the United States: a cross sectional study”.  BMC Psychiatry (2018) 18:130

 

Please click here to see the article.

Update in Cardiovascular Safety of Glucagon Like Peptide-1 Receptor Agonists In Patients With Type 2 Diabetes. A Mixed Treatment Comparison Meta-Analysis of Randomised Controlled Trials

Majed S. Al Yami, PharmD, BCPS, ASH-CHCa, Osamah M. Alfayez, PharmD, CDEb,c*, Razan Alsheikh, PharmD, BCPSb,d  "Update in Cardiovascular Safety of Glucagon Like Peptide-1 Receptor Agonists In Patients With Type 2 Diabetes. A Mixed Treatment Comparison Meta-Analysis of Randomised Controlled Trials”.  Heart, Lung and Circulation (2018)

 

Please click here to see the article.

Developed by:  EduTech / COP-ITS 2017